MAR 24, 2021 9:00 AM PDT

Residual Nucleic Acid Characterization of Cell Culture-Produced Vaccines and Biologics

Sponsored by: SCIEX
Speaker
  • Applications Scientist, SCIEX
    Biography

      Peter Holper obtained his degree in Biochemistry and Cell Biology from the University of California - San Diego. Peter has over 12 years of experience in biopharma, including as an analytical chemist at Eli Lilly and Company where he was responsible for developing the analytical control strategy for bioproducts. Peter currently works at SCIEX in Redwood City, CA (US) where he is responsible for developing and optimizing CE applications and providing customer demo sample analysis support.


    Abstract
    Date:  March 24, 2021
    Time: 9:00am (PST),  12:00pm (EST)
     
    Determination of residual host cell DNA and RNA are regulatory expectations as they pose potential safety concerns for cell culture-derived vaccines and other biologics. In addition to the quantity of residual DNA or RNA, the size distribution of residual DNA fragments is an important factor related to the oncogenicity and potential for infectivity. Due to the low amount of residual fragments present, developing an assay for with high sensitivity, specificity, and resolution can be a great challenge.
     
    Join Peter Holper from SCIEX to discover a new approach to finding a robust, sensitive sizing method for residual nucleic acid analysis.
     
    Learning Objectives
    • Get introduced to a new approach to analyze residual nucleic acids
    • Learn about key method features that ensure data quality and integrity
    • Discover a platform technique that can cover residual DNA and RNA
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
     

    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    Loading Comments...
    Show Resources
    Attendees
    • See more